ATGE Adtalem Global Education Inc.

Adtalem Global Education Appoints Dr. Charles DeShazer to Its Board of Directors

Adtalem Global Education (NYSE: ATGE), a leading workforce solutions provider, today announced the appointment of Dr. Charles DeShazer as an independent member of Adtalem’s board of directors.

“We are thrilled to welcome Charles to the Adtalem board. Charles’ impressive leadership experience across the healthcare services ecosystem, coupled with his background as a board-certified M.D. in internal medicine, will enable us to leverage his expertise in executing our strategy of becoming a leading provider of workforce solutions to the rapidly-evolving healthcare industry,” stated Lisa Wardell, chairman and CEO of Adtalem Global Education. “As technology accelerates changes in the way patients seek and receive care, Charles’ unique perspectives will greatly help us in further enhancing our programs and offerings to meet the evolving needs of our healthcare employer partners and addressing the critical talent shortages facing the sector.”

With this appointment, the Adtalem board of directors will be composed of 10 directors, nine of whom are independent. The board’s gender and ethnic composition includes four women and five persons of color, demonstrating Adtalem’s ongoing commitment to board diversity as a business imperative.

DeShazer currently serves as the director of clinical products at Google where he helps lead the design and implementation of an intelligent suite of tools that help healthcare providers deliver better patient care. Prior to this role, DeShazer served as the senior vice president and chief medical officer (CMO) of Highmark, Inc., one of the largest insurance organizations in the U.S from 2017 to 2021. In this role, he oversaw the company’s clinical strategy, overall medical leadership and provided oversight of Highmark, Inc.'s strategic direction and processes related to health care quality, efficiency and cost improvement. Additionally, as the CMO for the primary division of Highmark Health, DeShazer also interacted regularly with the smaller health system division, Allegheny Health Network, as well as Penn State Health, a large academic health system governed jointly by Penn State University and Highmark Health through a significant minority ownership investment. Prior to Highmark, DeShazer has served for more than 25 years in various executive leadership roles overseeing medical informatics, quality improvement, medical management and care delivery redesign across several organizations, including: a leading U.S. healthcare system, Baycare; health insurance companies, Humana and Highmark; and at the leading integrated health organization, Kaiser Permanente.

About Adtalem Global Education

The purpose of Adtalem Global Education is to empower students to achieve their goals, find success, and make inspiring contributions to our global community. Adtalem Global Education Inc. (NYSE: ATGE; member S&P MidCap 400 Index) is a leading global education provider and the parent organization of American University of the Caribbean School of Medicine, Association of Certified Anti-Money Laundering Specialists, Becker Professional Education, Chamberlain University, EduPristine, Ross University School of Medicine and Ross University School of Veterinary Medicine. For more information, please visit and follow on Twitter () and .

EN
31/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Adtalem Global Education Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Gap Supports Holding; Expecting Test of All-Time Highs We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). We will maintain our bullish view as long as market dynamics remain healthy and the S&P 500 (SPX) is above 5500. Our base case expectation is that SPX holds above short-term gap support at 5700-5785 (which is also where the 20-day, 100-day, and 200-day MAs all converge). However, if 5700 does break (a...

Adtalem Global Education Inc: 1 director

A director at Adtalem Global Education Inc sold 2,291 shares at 128.349USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Lockout Rally in Full Swing Continuing the trend from last week's U.S. Macro Vision (4/29/25), we are seeing more and more signs that lead us to believe the S&P 500 (SPX) made a major bottom at 4800-4820, which is where we initially discussed in our 4/8/25 Compass to look for a local bottom to develop. As a result, we have been short-term bullish since our 4/22/25 Compass, when we noted that the SPX was testing 5100-5120 support, a potential bounce spot and a level to trade long against. With t...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 and Nasdaq 100 Breaking Out We are seeing signs that this 2+ month consolidation in the S&P 500 and Nasdaq 100 (QQQ) is ready to break out to the upside. Part of that is the obvious; both the SPX and QQQ are breaking out to marginal new highs. The other part that has kept us bullish this whole time is that market dynamics have remained risk-on, which we have discussed on a weekly basis. Bottom line: our outlook remains bullish as long as the S&P 500 remains above 5770-5850. Our recommen...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch